The Valais-based start-up is accelerating the development of its lead candidate in partnership with the Geneva University Hospitals (HUG) and…

The EPFL spin-off Apolarion has obtained CHF 150,000 from Venture Kick to advance a chemical-free seed treatment technology powered by…

Lonza, the largest Swiss Health Valley🇨🇭 company, signs an agreement with Merck KGaA to acquire five CDMO manufacturing sites and…

Nagi Bioscience, an EPFL spin-off based at EPFL Innovation Park, has announced a new partnership with InVirtuoLabs, based in Ticino,…

Distalmotion, a global MedTech company based à Biopôle-Lausanne and focused on expanding access to robotic surgery in outpatient settings, announced…

The drug candidate, intended for the treatment of schizophrenia, is now set to enter Phase II. Addex holds a 20…

The Foundation for Innovation and Technology (FIT) is supporting three life sciences start-ups through Tech Seed loans. Biodelphis Therapeutics is…

About fifteen exhibitors will be waiting for you at the BioAlps Networking Day on 19 November 2026 at Beaulieu Lausanne….

Release Therapeutics, a privately held Swiss BioMedTech company based at Campus Biotech in Geneva, announced that it has been awarded…

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to CINAINU® (LH-8), an investigational topical treatment for…

Geneva University Hospitals (HUG) are now Switzerland’s most advances hospital in the digital field. In the 2027 edition of Newsweek…

dEEGtal, S-SENTIA and Juturna Bio are the latest projects to receive funding from the FIF, the Canton of Geneva’s innovation…